• Home
  • About
    • Who we are
    • Leadership
      • Board
      • Senior Management
    • Our Impact
  • Our work
    • RMNCAH
    • Gender & GBV
    • HIV/AIDS & STI
    • Adolescent & AGYW
    • Child Protection
    • Third Party Monitoring & Evaluation
  • Resources
    • Publications
    • Report
    • Infographics
  • Get Involved
    • Careers
    • Partnerships
    • Contacts
  • Media Center
    • Gallery
    • Success Stories
    • News & Updates
      • Blogs
      • News
  • Home
  • About
    • Who we are
    • Leadership
      • Board
      • Senior Management
    • Our Impact
  • Our work
    • RMNCAH
    • Gender & GBV
    • HIV/AIDS & STI
    • Adolescent & AGYW
    • Child Protection
    • Third Party Monitoring & Evaluation
  • Resources
    • Publications
    • Report
    • Infographics
  • Get Involved
    • Careers
    • Partnerships
    • Contacts
  • Media Center
    • Gallery
    • Success Stories
    • News & Updates
      • Blogs
      • News

A prospective study of vaginal trichomonas’s and HIV-1 shedding in women on antiretroviral therapy

Author image
ICRHK
Research publications

Linnet N Masese 1, Susan M Graham, Ruth Gitau, Nobert Peshu, Walter Jaoko, Jeckoniah O Ndinya-Achola, Kishorchandra Mandaliya, Barbra A Richardson, Julie Overbaugh, R Scott McClelland

Affiliation

  • 1Department of Epidemiology, Box 357236, University of Washington, Seattle, Washington 98195, USA. linnet@uw.edu

PMID: 22047086 PMCID: PMC3231993

DOI: 10.1186/1471-2334-11-307

Abstract

Background: Trichomonas vaginalis has been associated with increased vaginal HIV-1 RNA shedding in antiretroviral therapy (ART)-naïve women. The effect of trichomoniasis on vaginal HIV-1 shedding in ART-treated women has not been characterized. We tested the hypothesis that T. vaginalis infection would increase vaginal HIV-1 RNA shedding in women on ART, and that successful treatment would reduce vaginal HIV-1 RNA levels.

Methods: We conducted a prospective cohort study including monthly follow-up of 147 women receiving ART in Mombasa, Kenya. Those with T. vaginalis infection, defined by the presence of motile trichomonads on vaginal saline wet mount, received treatment with single dose metronidazole (2 g). Test of cure was performed at the next monthly visit. Using the pre-infection visit as the reference category, we compared detection of vaginal HIV-1 RNA before versus during and after infection using generalized estimating equations. A cut-off of 100 HIV-1 RNA copies/swab was used as the lower limit for linear quantitation.

Results: Among 31 women treated for trichomoniasis, the concentration of vaginal HIV-1 RNA was above the limit for quantitation before, during, and after T. vaginalis infection in 4 (13% [95% CI 4% – 30%]), 4 (13% [95% CI 4% – 30%]), and 5 (16% [95% confidence interval {CI} 5% – 34%]) women respectively. After adjusting for potential confounding factors, we could detect no difference in the likelihood of detecting vaginal HIV-1 RNA before versus during infection (odds ratio [OR] 1.41, 95% CI 0.23 – 8.79, p = 0.7). In addition, detection of HIV-1 RNA was similar before infection versus after successful treatment (OR 0.68, 95% CI (0.13 – 3.45), p = 0.6).

Conclusion: Detection of vaginal HIV-1 RNA during ART was uncommon at visits before, during and after T. vaginalis infection.

Link

https://pubmed.ncbi.nlm.nih.gov/22047086/

Tags :
2011
Share This Post

Centre of excellence in implemention of research and intevention in public health, including sexual reproductive health.

Phone No:

+254 722 208 652 | +254 734 466 466

Email

info@icrhk.org

Quick Links

  • Privacy Policy
  • Upcoming Events
  • Careers
X-twitter Facebook-f Youtube Linkedin

About

  • Who we are
  • Success Stories
  • Blog

Our Offices

Mombasa Office

ICRHK Tudor Office, Off Nyali Bridge, next to MM & MV Shah Academy-Tudor Mombasa, Kenya

Nairobi Office

Starwood Apartments 2nd floor B5, Argwings Kodhek Road, Hurlingham

© All rights reserved ICRHK 2025

Made with ❤ by iDeveloper Technologies Ltd
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.